Chimeric MDM2 minigenes were created by replacing the introns and/or internal exon of MDM2 with corresponding regions from the stress-responsive p53 minigene. These minigenes were then spliced in vitro in nuclear extracts prepared from normal (N) and cisplatinum (C) treated cells. RNA was extracted using phenol/chloroform, reversed transcribed, and subjected to a 25-cycle PCR using (a) representative splicing reactions from MDM2 chimeric minigene +ATP reactions. *Indicates non-specific band unspliced products are depicted in the 7-I7-8.9
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7-I7-8-I8-9 7-I3/10-8-I11-9 7-I3/10-8-I8-9 7-I3/10-8-I8-9 7-I7-8-I11-9 7-I3/10-11-I11-9 RNA was extracted and subjected to RT-PCR using a minigene and gene-specific primer. PCR products were separated on a 1.5% agarose gel and spliced products were visualized by UV imaging. The SRSF1-48 mutant does not lose damage-inducible alternative splicing of exon 11 (n=3).
